Progression of LNCaP prostate tumor cells during androgen deprivation:: Hormone-independent growth, repression of proliferation by androgen, and role for p27Kip1 in androgen-induced cell cycle arrest

被引:217
作者
Kokontis, JM
Hay, N
Liao, SS
机构
[1] Univ Chicago, Ben May Inst Canc Res, Chicago, IL 60637 USA
[2] Univ Chicago, Dept Physiol & Pharmacol, Chicago, IL 60637 USA
[3] Univ Chicago, Dept Biochem & Mol Biol, Chicago, IL 60637 USA
关键词
D O I
10.1210/me.12.7.941
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The molecular mechanism of androgen-independent growth of prostate cancer after androgen ablation was explored in LNCaP cells. An androgen-dependent clonal subline of the LNCaP human prostate carcinoma cell line, LNCaP 104-S, progressed to a slow growing stage (104-R1) and then to a faster growing stage (104-R2) during more than 2 yr of continuous culture in the absence of androgen. Androgen-induced proliferation of 104-S cells is inhibited by the antiandrogen Casodex, while proliferation of 104-R1 and 104-R2 cells is unaffected by Casodex. This indicates that proliferation of 104-R1 and 104-R2 cells is not supported by low levels of androgen in the culture medium. Compared with LNCaP 104-S cells, both 104-R1 and 104-R2 cells express higher basal levels of androgen receptor (AR), and proliferation of these two cell lines is paradoxically repressed by androgen. After continuous passage in androgen-containing medium, 104-R1 cells reverted back to an androgen-dependent phenotype. The mechanism of androgenic repression of 104-R1 and 104-R2 sublines was further evaluated by examining the role of critical regulatory factors involved in the control of cell cycle progression. At concentrations that repressed growth, androgen transiently induced the expression of the cyclin-dependent kinase (cdk) inhibitor p21(waf1/cip1) in 104-R1 cells, while expression of the cdk inhibitor p27(Kip1) was persistently induced by androgen in both 104-R1 and 104-R2 cells. Induced expression of murine p27(Kip1) in 104-R2 cells resulted in G1 arrest. Specific immunoprecipitates of Cdk2 but not Cdk4 from androgen-treated 104-R1 cells contained both p21(waf1/cip1) and p27(Kip1). This observation was confirmed by in vitro assay of histone H1 and Rb (retinoblastoma protein) phosphorylation by the proteins associated with the immune complex. Furthermore, inhibition of Cdk2 activity correlated with the accumulation of p27(Kip1) and not p21(waf1/cip1). From these results we conclude that androgenic repression of LNCaP 104-R1 and 104-R2 cell proliferation is due to the induction of p27(Kip1) which in turn inhibits Cdk2, a factor critical for cell cycle progression and proliferation.
引用
收藏
页码:941 / 953
页数:13
相关论文
共 71 条
[51]   Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16(INK4a) [J].
Serrano, M ;
Lin, AW ;
McCurrach, ME ;
Beach, D ;
Lowe, SW .
CELL, 1997, 88 (05) :593-602
[52]   INHIBITORS OF MAMMALIAN G(1) CYCLIN-DEPENDENT KINASES [J].
SHERR, CJ ;
ROBERTS, JM .
GENES & DEVELOPMENT, 1995, 9 (10) :1149-1163
[53]   COMPARISON OF TESTOSTERONE-METABOLISM IN BENIGN PROSTATIC HYPERPLASIA AND HUMAN PROSTATE-CANCER CELL-LINES IN-VITRO [J].
SMITH, CM ;
BALLARD, SA ;
WYLLIE, MG ;
MASTERS, JRW .
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 1994, 50 (3-4) :151-159
[54]  
Soto AM, 1995, ONCOL RES, V7, P545
[55]   IDENTIFICATION OF A MYC-DEPENDENT STEP DURING THE FORMATION OF ACTIVE G(1) CYCLIN-CDK COMPLEXES [J].
STEINER, P ;
PHILIPP, A ;
LUKAS, J ;
GODDENKENT, D ;
PAGANO, M ;
MITTNACHT, S ;
BARTEK, J ;
EILERS, M .
EMBO JOURNAL, 1995, 14 (19) :4814-4826
[56]  
THALMANN GN, 1994, CANCER RES, V54, P2577
[57]  
TOKUNAGA K, 1987, CANCER RES, V47, P5616
[58]   Human prostate tumor growth in athymic mice: Inhibition by androgens and stimulation by finasteride [J].
Umekita, Y ;
Hiipakka, RA ;
Kokontis, JM ;
Liao, S .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (21) :11802-11807
[59]   ANDROGEN RECEPTORS IN ENDOCRINE-THERAPY-RESISTANT HUMAN PROSTATE-CANCER [J].
VANDERKWAST, TH ;
SCHALKEN, J ;
DEWINTER, JAR ;
VANVROONHOVEN, CCJ ;
MULDER, E ;
BOERSMA, W ;
TRAPMAN, J .
INTERNATIONAL JOURNAL OF CANCER, 1991, 48 (02) :189-193
[60]   THE HUMAN PROSTATIC-CARCINOMA CELL-LINE LNCAP AND ITS DERIVATIVES - AN OVERVIEW [J].
VANSTEENBRUGGE, GJ ;
GROEN, M ;
VANDONGEN, JW ;
BOLT, J ;
VANDERKORPUT, H ;
TRAPMAN, J ;
HASENSON, M ;
HOROSZEWICZ, J .
UROLOGICAL RESEARCH, 1989, 17 (02) :71-77